atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic ...

The 5 Stages of Psychedelic Psychotherapy

For anyone interested in psychedelic psychotherapy, this post showcases the whole process of this new therapeutic approach, from start to finish.

Consolidation in psychedelics as atai pairs with Beckley

Beckley Psytech has agreed to merge with atai Life Sciences in a deal that would bring together two psychedelic medicine pioneers

Atai Life Sciences plans to merge with psychedelic startup Beckley Psytech

Two companies trying to develop psychedelic medicines make a deal at a time when the Trump administration has expressed support for the field.

atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic ...

Strategic combination establishes a market-leading mental health company with a pipeline that includes potentially transformative, rapid-acting psychedelic assets differentiated by their convenient route of administration and short time-in-clinicCombined company will operate under the name atai Beckley with a joint leadership…

Durham Life Sciences Company Eyes $20M Expansion - Connect CRE

BioAgilytix, a bioanalytical laboratory that works with pharmaceutical and biotechnology companies on drug development, is expanding on its already robust Durham footprint. The company is building a 26,000 square foot lab space to support two other sprawling buildings in the area. The Triangle Business Journal reports BoAgilytix recently completed a 76,000-square-foot facility on South Miami Boulevard in Durham to go along with the company’s 87,…

atai and Beckley to combine establishing market leader in psychedelic mental health therapies - BioTuesdays

atai Life Sciences (NASDAQ: ATAI) and closely held Beckley Psytech announced a definitive agreement to combine in an all-share transaction subject to Phase 2b success criteria of BPl-003 in patients with treatment-resistant depression (TRD). According to atai, the transaction is expected to close in the second half of 2025 with the combined company operating under the name atai Beckley. Srinivas Rao, MD, Ph.D., CEO and co-founder of atai, commen…